Your browser doesn't support javascript.
loading
Feasibility of multi-parametric PET and MRI for prediction of tumour recurrence in patients with glioblastoma.
Lundemann, Michael; Munck Af Rosenschöld, Per; Muhic, Aida; Larsen, Vibeke A; Poulsen, Hans S; Engelholm, Svend-Aage; Andersen, Flemming L; Kjær, Andreas; Larsson, Henrik B W; Law, Ian; Hansen, Adam E.
Afiliação
  • Lundemann M; Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. michael.juncker.lundemann@regionh.dk.
  • Munck Af Rosenschöld P; Department of Oncology, Section for Radiotherapy, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. michael.juncker.lundemann@regionh.dk.
  • Muhic A; Niels Bohr Institute, Department of Science, University of Copenhagen, Copenhagen, Denmark. michael.juncker.lundemann@regionh.dk.
  • Larsen VA; Niels Bohr Institute, Department of Science, University of Copenhagen, Copenhagen, Denmark.
  • Poulsen HS; Radiation Physics, Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Scania, Sweden.
  • Engelholm SA; Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Andersen FL; Department of Radiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Kjær A; Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Larsson HBW; Department of Oncology, Section for Radiotherapy, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Law I; Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Hansen AE; Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Eur J Nucl Med Mol Imaging ; 46(3): 603-613, 2019 03.
Article em En | MEDLINE | ID: mdl-30276440
ABSTRACT

BACKGROUND:

Recurrence in glioblastoma patients often occur close to the original tumour and indicates that the current treatment is inadequate for local tumour control. In this study, we explored the feasibility of using multi-modality imaging at the time of radiotherapy planning. Specifically, we aimed to identify parameters from pre-treatment PET and MRI with potential to predict tumour recurrence. MATERIALS AND

METHODS:

Sixteen patients were prospectively recruited and treated according to established guidelines. Multi-parametric imaging with 18F-FET PET/CT and 18F-FDG PET/MR including diffusion and dynamic contrast enhanced perfusion MRI were performed before radiotherapy. Correlations between imaging parameters were calculated. Imaging was related to the voxel-wise outcome at the time of tumour recurrence. Within the radiotherapy target, median differences of imaging parameters in recurring and non-recurring voxels were calculated for contrast-enhancing lesion (CEL), non-enhancing lesion (NEL), and normal appearing grey and white matter. Logistic regression models were created to predict the patient-specific probability of recurrence. The most important parameters were identified using standardized model coefficients.

RESULTS:

Significant median differences between recurring and non-recurring voxels were observed for FDG, FET, fractional anisotropy, mean diffusivity, mean transit time, extra-vascular, extra-cellular blood volume and permeability derived from scans prior to chemo-radiotherapy. Tissue-specific patterns of voxel-wise correlations were observed. The most pronounced correlations were observed for 18F-FDG- and 18F-FET-uptake in CEL and NEL. Voxel-wise modelling of recurrence probability resulted in area under the receiver operating characteristic curve of 0.77 from scans prior to therapy. Overall, FET proved to be the most important parameter for recurrence prediction.

CONCLUSION:

Multi-parametric imaging before radiotherapy is feasible and significant differences in imaging parameters between recurring and non-recurring voxels were observed. Combining parameters in a logistic regression model enabled patient-specific maps of recurrence probability, where 18F-FET proved to be most important. This strategy could enable risk-adapted radiotherapy planning.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imageamento por Ressonância Magnética / Glioblastoma / Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imageamento por Ressonância Magnética / Glioblastoma / Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article